Groundbreaking Clinical Study Reveals Avmacol® Reduces Ki-67 Markers in Former Smokers at High Risk for Lung Cancer A new clinical study demonstrates that Avmacol® effectively decreases Ki-67 markers in former smokers, indicating potential for lung cancer prevention. Results promote further research in this area.

Groundbreaking Clinical Study Reveals Avmacol® Reduces Ki-67 Markers in Former Smokers at High Risk for Lung Cancer #USA #Lancaster #Lung_Cancer #Avmacol #Sulforaphane